Chordate Medical announced that Otto Skolling was elected Vice Chairman of the Board. Otto Skolling has over 30 years of experience in product development, business development and project management within the pharmaceutical and medical technology industry. BioStock contacted Otto Skolling to find out more about his expectations for the role as Vice Chairman of the Board of Chordate Medical.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0568 SEK | -0.35% | +9.23% | -64.59% |
06-13 | Chordate Medical Holding AB Enters New Partnership Agreement with Neurolite AG | CI |
05-24 | Chordate Medical Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-64.59% | 2.63M | |
+7.77% | 218B | |
+10.16% | 189B | |
+26.21% | 151B | |
+32.78% | 113B | |
+1.98% | 64.02B | |
+14.48% | 52.6B | |
+2.92% | 49.85B | |
-6.60% | 37.89B | |
-1.07% | 34.92B |
- Stock Market
- Equities
- CMH Stock
- News Chordate Medical Holding AB
- Otto Skolling Elected to Chordate Medical's Board